Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Gregory P Bisson"'
Autor:
Christopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, Jotam Pasipanodya, Shashikant Srivastava, Chawangwa Modongo, Nicola M Zetola, Drew Weissman, Tawanda Gumbo, Gregory P Bisson
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187624 (2017)
Pyrazinamide is the main driver of sterilizing effect in the standard regimen in adults and older children, and this effect is concentration-dependent. Tuberculosis patients co-infected with human immunodeficiency virus (HIV) have an increased risk f
Externí odkaz:
https://doaj.org/article/f1ea380e4fbf4d8faf32e172a3a16b79
Publikováno v:
Public Health in Practice, Vol 7, Iss , Pp 100483- (2024)
Objectives: In the United States, a federal emergency program has made SARS-CoV-2 self-test kits available at no cost. It is unclear how widely free tests are preferred. We conducted a survey to estimate the proportion of respondents who do not prefe
Externí odkaz:
https://doaj.org/article/8808d654ac444ff3b226412337afad4c
Autor:
Sara C Auld, Eleanor S Click, Charles M Heilig, Roque Miramontes, Kevin P Cain, Gregory P Bisson, William R Mac Kenzie
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78779 (2013)
BACKGROUND: Although the tuberculin skin test (TST) is frequently used to aid in the diagnosis of tuberculosis (TB) disease and to identify persons with latent TB infection, it is an imperfect test and approximately 10-25% of persons with microbiolog
Externí odkaz:
https://doaj.org/article/2e6a05e7794347ce998646175b9c58ce
Autor:
Katherine T Steele, Andrew P Steenhoff, Craig W Newcomb, Tumelo Rantleru, Rudo Nthobatsang, Gloria Lesetedi, Scarlett L Bellamy, Jean B Nachega, Robert Gross, Gregory P Bisson
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20010 (2011)
BackgroundAdverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Saharan Africa, despite reports of high levels of ART adherence in this setting. We sought to determine the relationship between very early ART
Externí odkaz:
https://doaj.org/article/312e17cef2cb473a9a7c9b7c21300360
Autor:
Gregory P Bisson
Publikováno v:
PLoS Medicine, Vol 8, Iss 1, p e1000392 (2011)
In this Perspective, Gregory Bisson discusses a new article by Matthias Egger and colleagues that introduces a simple method for HIV treatment programs to more accurately estimate the proportion of patients dying in the first year after ART initiatio
Externí odkaz:
https://doaj.org/article/3ff5561617264fc79eaa4de521ef182b
Autor:
Amita Gupta, Girish Nadkarni, Wei-Teng Yang, Aditya Chandrasekhar, Nikhil Gupte, Gregory P Bisson, Mina Hosseinipour, Naveen Gummadi
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28691 (2011)
We systematically reviewed observational studies of early mortality post-antiretroviral therapy (ART) initiation in low- and middle-income countries (LMIC) in Asia, Africa, and Central and South America, as defined by the World Bank, to summarize wha
Externí odkaz:
https://doaj.org/article/e0951f110ef64440a15e09701a584584
Autor:
Gregory P Bisson, Jeffrey S A Stringer
Publikováno v:
PLoS Medicine, Vol 6, Iss 10, p e1000174 (2009)
Gregory Bisson and Jeffrey Stringer discuss the implications of a new study showing how loss to follow-up affects the effectiveness of a public sector HIV program in Côte d'Ivoire.
Externí odkaz:
https://doaj.org/article/989cc260aef246c785792acdc84c92c4
Autor:
Gregory P Bisson, Robert Gross, Scarlett Bellamy, Jesse Chittams, Michael Hislop, Leon Regensberg, Ian Frank, Gary Maartens, Jean B Nachega
Publikováno v:
PLoS Medicine, Vol 5, Iss 5, p e109 (2008)
World Health Organization (WHO) guidelines for monitoring HIV-infected individuals taking combination antiretroviral therapy (cART) in resource-limited settings recommend using CD4(+) T cell (CD4) count changes to monitor treatment effectiveness. In
Externí odkaz:
https://doaj.org/article/58c0fd8078524d8f894bb7c150de90c0
Autor:
Gregory P Bisson, Tendani Gaolathe, Robert Gross, Caitlin Rollins, Scarlett Bellamy, Mpho Mogorosi, Ava Avalos, Harvey Friedman, Diana Dickinson, Ian Frank, Ndwapi Ndwapi
Publikováno v:
PLoS ONE, Vol 3, Iss 3, p e1725 (2008)
Monitoring the effectiveness of global antiretroviral therapy scale-up efforts in resource-limited settings is a global health priority, but is complicated by high rates of losses to follow-up after treatment initiation. Determining definitive outcom
Externí odkaz:
https://doaj.org/article/31426d16048a4730ad38082a6fbdeb0d
Autor:
Yeonsoo Baik, Pholo Maenetje, Diana Schramm, Caroline Tiemessen, Itai Ncube, Gavin Churchyard, Robert Wallis, Mboyo-di-tamba Vangu, Hardy Kornfeld, Yun Li, Sara C. Auld, Gregory P. Bisson
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Patients with tuberculosis (TB) and HIV often present with impairments in lung function and exercise capacity after treatment. We evaluated clinical and immunologic variables associated with a minimum clinically important differen
Externí odkaz:
https://doaj.org/article/19eaeaebfb4c4c90a81280d5baa856f7